Objectives: To test CIDP patients for IgG positivity towards NF155 and NF140.
Samples:
For NF155:
CODE | RESULT |
---|---|
46 | - |
47 | - |
48 | - |
49 | - |
50 | - |
51 | - |
52 | - |
53 | - |
54 | - |
55 | - |
56 | - |
57 | - |
58 | - |
59 | - |
60 | - |
61 | - |
62 | - |
63 | - |
64 | - |
65 | - |
66 | - |
67 | - |
68 | - |
69 | - |
70 | - |
71 | - |
72 | - |
73 | - |
74 | - |
75 | - |
76 | - |
77 | - |
CTRL - | - |
CTRL + | + |
For NF140:
CODE | RESULT |
---|---|
46 | - |
47 | - |
48 | - |
49 | - |
50 | - |
51 | - |
52 | - |
53 | - |
54 | - |
55 | - |
56 | - |
57 | - |
58 | - |
59 | - |
60 | - |
61 | - |
62 | - |
63 | - |
64 | - |
65 | - |
66 | - |
67 | - |
CTRL - | - |
CTRL + | + |
NF155, NF140 ICC:
- HEKs 293 Cells Transfection: 2018.01.16 /30.05.2018
- Blocking solution: 5% goat serum in PBS.
- Patient’s sera diluted 1/100 for IgG with 5% goat serum in PBS.
- Primary antibody: AF3235 diluted 1/1000.
- Secondary antibodies: GAC 488 (1/1000) + GAH 594 IgG (1/1000)
- Vectashield mounting medium.
Results: All samples were negative.